Zapata Quantum (ZPTA) director details large share and option stakes
Rhea-AI Filing Summary
Zapata Quantum, Inc. director Golestani Clark filed an amended initial ownership report listing a substantial equity position in the company. The filing shows direct ownership of 32,626,288 shares of Common Stock.
Clark also holds a range of equity-linked awards. These include stock options covering 1,000,000 shares at an exercise price of $0.08 per share expiring on October 9, 2030, and warrants for 1,250,000 shares at $0.04 per share expiring on June 12, 2030. A convertible promissory note for $100,000 is convertible into 2,500,000 shares at $0.04 per share until June 12, 2026.
The filing also reports 75,000 restricted stock units that convert into common stock on a one-for-one basis, plus additional stock options for 68,558 shares at $3.80 expiring on July 31, 2033 and 34,279 shares at $2.02 expiring on February 4, 2031. Footnotes describe various vesting schedules for restricted stock, RSUs, and options, including 32,500,000 shares of restricted stock vesting in equal monthly installments over two years. The report reflects holdings only and does not show new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Convertible Promissory Note | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- 32,500,000 of the shares of restricted stock vest in equal monthly installments over a two-year period. 100% of the shares subject to the option are fully vested and exercisable. The stock options are fully vested and exercisable. Restricted stock units convert into shares of common stock on a one-for-one basis. The restricted stock units will vest in three equal installments, with 25,000 shares of common stock vesting on October 10, 2024, 25,000 shares of common stock vesting on January 10, 2025, and 25,000 shares vesting on the date of the 2025 annual meeting of the Issuer's stockholders. The Reporting Person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to continued service as a director of the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement.